New Studies Validating the Uniqueness of the BVA-100® Blood Test for Heart Failure Patients Compared to Pressure Measures
October 03, 2022 08:00 ET
|
Daxor Corporation
Presented at Key Scientific Society Meeting -Commonly Used Pressure Measures for Volume Assessment Proven Not Equivalent to BVA Oak Ridge, TN, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation...
Daxor Corporation to Exhibit at the Annual Scientific Meeting of the Heart Failure Society of America
September 26, 2022 08:00 ET
|
Daxor Corporation
Compelling New Patient Outcome Data to be Presented Oak Ridge, TN, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology,...
QHSLab, Inc. Launches a “Long COVID” Digital Health Tool for Primary Care Physicians
September 20, 2022 08:30 ET
|
QHSLab, Inc.
Primary care physicians now have access to reimbursable digital tools for the routine assessment of post-COVID conditions Strengthening QHSLab’s Business Model and Expanding Digital Health Product...
Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference
September 06, 2022 17:05 ET
|
Daxor Corporation
Oak Ridge, TN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh...
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders
August 29, 2022 08:00 ET
|
Daxor Corporation
Oak Ridge, TN, Aug. 29, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it issued a corporate update in a Letter...
Daxor Corporation Reports a 92.6 Percent Revenue Increase in Diagnostic Operating Division in Form N-CSR Filing for the Six Months Ended June 30, 2022
August 25, 2022 16:05 ET
|
Daxor Corporation
Conference Call to be held today at 4:30 p.m. Eastern Time Oak Ridge, TN, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology,...
Daxor Corporation to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update
August 24, 2022 16:40 ET
|
Daxor Corporation
Conference Call to be held on the same day at 4:30 p.m. Eastern Time Oak Ridge, TN, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...
Aviv Clinics and Sagol Center for Hyperbaric Medicine and Research Present Webinar on Research Findings from the First Long COVID Clinical Trial to Show Symptom Relief
August 24, 2022 09:00 ET
|
Aviv Clinics
ORLANDO, Fla., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Aviv Clinics and Sagol Center for Hyperbaric Medicine and Research (Sagol Center) at Shamir Medical Center announce a live webinar with Dr. Shai...
DAXOR COMPLETES NIH FUNDED I-CORPS PROGRAM FOR COMMERCIALIZATION OF CLINICAL DECISION SUPPORT SOFTWARE
July 18, 2022 08:00 ET
|
Daxor Corporation
Company Received Funding from NIH to Accelerate New Clinical Decision Support Software For Use With Daxor’s Blood Volume Analyzer for Heart Failure Treatment Oak Ridge, TN, July 18, 2022 (GLOBE...
Panacea Life Sciences Announces Launch of CBDA Oil Drops as Potential Complementary Treatment for Long COVID
July 14, 2022 07:00 ET
|
Panacea Life Sciences Holdings, Inc.
GOLDEN, Colo., July 14, 2022 (GLOBE NEWSWIRE) -- Panacea Life Sciences Holdings, Inc. (OTCQB: PLSH) (“Panacea” or the “Company”), a Colorado, USA-based cannabinoid research-focused company providing...